Business Description
HTG Molecular Diagnostics Inc
NAICS : 334510
SIC : 3826
ISIN : US40434H3021
Description
HTG Molecular Diagnostics Inc is a life science company whose mission is to advance precision medicine through its transcriptome-wide profiling and medicinal chemistry technologies. The company derives revenue from sales of its HTG EdgeSeq system and integrated next-generation sequencing-based HTG EdgeSeq research use only assays and from sample processing services performed in its VERI/O laboratory. The company operates in one segment and its customers and distributors are located in the United States and Europe.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -271.17 | |||||
OCF Margin % | -270.83 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HTGMQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HTG Molecular Diagnostics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.215 | ||
| EPS (TTM) ($) | -17.8 | ||
| Beta | 22.2724 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.81 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.0001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0001 | ||
| Shares Outstanding (Mil) | 2.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HTG Molecular Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HTG Molecular Diagnostics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 137 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 52 days | ||
| First quarter earnings results for 2026 | 2026-07-13 | In 14 days | ||
| General meeting for 2025 | 2026-07-06 | In 7 days | ||
| Annual report for 2025 | 2026-06-29 | -- | ||
| First quarter earnings results for 2026 | 2026-04-20 | 0.00 (+0.00%) | ||
| Annual report for 2025 | 2026-04-13 | 0.00 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-13 | 0.00 (+0.00%) | ||
| General meeting for 2025 | 2026-04-08 | 0.00 (+0.00%) | ||
| 0.0833333:1 Stock Split | 2022-12-21 | 7.50 (-22.79%) |
Show
Entries
HTG Molecular Diagnostics Inc Frequently Asked Questions
What is HTG Molecular Diagnostics Inc(HTGMQ)'s stock price today?
The current price of HTGMQ is $0.00. The 52 week high of HTGMQ is $0.00 and 52 week low is $0.00.
When is next earnings date of HTG Molecular Diagnostics Inc(HTGMQ)?
The next earnings date of HTG Molecular Diagnostics Inc(HTGMQ) is 2026-07-13 Est..
Does HTG Molecular Diagnostics Inc(HTGMQ) pay dividends? If so, how much?
HTG Molecular Diagnostics Inc(HTGMQ) does not pay dividend.
Guru Commentaries on OTCPK:HTGMQ
No articles.
Press Release
Articles on HTG Molecular Diagnostics Inc
No articles.